Vaccines to Watch in 2024
Drug Topics
MARCH 19, 2024
Moderna, Merck, and Pfizer-BioNTech are leading the charge with new vaccines for respiratory viruses in development.
Sat.Mar 16, 2024 - Fri.Mar 22, 2024
498 
Patient centricity for tailor-made healthcare
European Pharmaceutical Review
MARCH 21, 2024
Can you tell us a bit about yourself and your role at Pfizer? I’m a pharmacist with an MBA and PhD. My PhD thesis is about considerations in the production and purchasing of drugs. I joined Pfizer in January 2023 as a health access specialist, after working at Clalit Health Services in Israel for almost 20 years. At Clalit, which is the second largest healthcare provider in the world, I worked in several management positions and gained a broad understanding of the needs and constraints of a heal
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Adaptation Is the Key to Success
Drug Topics
MARCH 21, 2024
Farmers and welders have adapted to work with the current times. Pharmacists should consider adapting their profession as well.
Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM
Pharmacy Times
MARCH 18, 2024
Michael Singel, PharmD, discusses the role of pharmacists in the operationalization of bispecifics to treat multiple myeloma, including the creation of treatment plans and standard of care order sets.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PAP 2024: Teaming Up on Patient Assistance
Pharmaceutical Commerce
MARCH 21, 2024
Presentation discusses the evolution of the patient assistance landscape, while presenting ways to collaborate.
3D printing and personalised medicines: embracing innovative technologies
Hospital Pharmacy Europe
MARCH 21, 2024
Supporting the successful compounding of drugs with 3D printing processes has the potential to not only fulfil unmet patient needs but also drive efficiencies in hospital pharmacies. Ian Soulairol from the Institut Charles Gerhardt Montpellier at Montpellier University and pharmacist at the Department of Pharmacy of Nîmes University Hospital in France shares insights into how this technology is evolving and what it means for clinical practice now and in the future. 3D printing, or additive manuf
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Five Things To Know: How To Use Artificial Intelligence To Be A Better Clinical Pharmacist
IDStewardship
MARCH 17, 2024
In this article a clinical pharmacist with experience and knowledge about using artificial intelligence describes how it can be used to be a better clinical pharmacist. Authored By: Steven Smoke, Pharm.D., BCIDP, BCPT Article Posted 18 March 2024 In healthcare’s evolving landscape, artificial intelligence (AI) promises to redefine pharmacy. AI chatbots like ChatGPT and Gemini offer not-so-subtle hints at AI’s transformative potential.
An ocean of answers in a single cell — how proteomics can lead to better drugs
PharmaVoice
MARCH 21, 2024
New tools that allow researchers to separate single cells can help map the complex web of proteins that lead to disease, providing new targets for biopharma.
Study: Researchers Identify 25 Air Pollutants Associated With Asthma Symptoms
Pharmacy Times
MARCH 16, 2024
Investigators found that 1,1,1 trichloroethane; 2-nitropropane; and 2,4,6 trichlorophenol were significantly associated with asthma symptoms for 3 exposure periods.
Local Pharmacy Access in the United States Significantly Lower in Rural Areas
Drug Topics
MARCH 21, 2024
Researchers collected data to measure inequities in pharmacy access across the country.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
FDA authorizes new drug to protect immune compromised from Covid-19
STAT
MARCH 22, 2024
The Food and Drug Administration on Friday authorized a new antibody to protect immunocompromised individuals against Covid-19. The drug, known as Pemgarda and marketed by the biotech Invivyd, is the first such drug to become available since the agency pulled AstraZeneca’s Evusheld off the market in January 2023. New Omicron variants had rendered Evusheld ineffective.
GSK has the U.S. shingles vaccine market cornered. A jab with fewer side effects could change that.
PharmaVoice
MARCH 19, 2024
Curevo Vaccine is readying a phase 3 trial for a candidate it believes could have an edge over GSK’s blockbuster Shingrix.
New Compound Found in Edible Mushroom May Pave the Way for Antioxidant-Based Medicines
Pharmacy Times
MARCH 20, 2024
The study represents a new era of research into mushrooms as a resource for pharmaceutical development.
FDA Approves Aprocitentan For Treatment of Uncontrolled High Blood Pressure
Drug Topics
MARCH 20, 2024
Aprocitentan (TRYVIO) from pharmaceutical company Idorsia demonstrated statistically significant and clinically meaningful reductions in blood pressure in combination with other antihypertensive therapies.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Gene-edited pig kidney transplanted into a living patient for the first time
STAT
MARCH 21, 2024
In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday that, for the first time, it had transplanted a kidney from a CRISPR gene-edited pig into a living patient. Surgeons performed the milestone procedure over four hours on Saturday, March 16, without complications. As of Thursday morning, the organ recipient, a 62-year-old man named Richard Slayman, was “recovering well” and expected to be discharged soon, the hospital said in a
Ex-Novartis exec sets out to create ‘Apple of AI’
PharmaVoice
MARCH 18, 2024
Aily Labs’ tech makes predictive business decisions for life science companies and comes from a need its founder witnessed in Big Pharma.
As Cannabis Use Increases, Pharmacists Must Be Prepared to Counsel Patients
Pharmacy Times
MARCH 22, 2024
As more states have legalized cannabis use—both medicinal and recreational—Sera said pharmacists’ roles in counseling will become even more important.
Psilocybin Side Effects Found to be Tolerable, Resolve Within 2 Days
Drug Topics
MARCH 22, 2024
Results from a meta-analysis on the side of effects of the psychedelic psilocybin were presented at the 2024 American Pharmacists Association Annual Meeting & Exposition.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives
STAT
MARCH 20, 2024
Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures.
Providers 'wasted' $10.6B in 2022 overturning claims denials, survey finds
Fierce Healthcare
MARCH 21, 2024
More than 100 provider organizations want the Centers for Medicare & Medicaid Services (CMS) to take a tougher stance on Medicare Advantage (MA) plans’ practices following an industry survey es | Providers spent nearly $20 billion in 2022 pursuing delays and denials across all payer types, yet those efforts are substantially more costly on average when dealing with private plans, hundreds of hospitals and health systems told Premier in a recent survey.
FDA Expands Label for Bempedoic Acid to Reduce Cardiovascular Risk, With or Without Statins
Pharmacy Times
MARCH 22, 2024
Bempedoic acid (Nexletol; Esperion) and bempedoic acid and ezetimibe (Nexlizet; Esperion) are the only LDL-C lowering non-statin drugs indicated for primary prevention patients.
Novavax COVID-19 Vaccine Shows Lasting Protection Against Delta Variant
Drug Topics
MARCH 19, 2024
The biotechnology company’s recombinant spike protein-based vaccine demonstrated an efficacy of 88% after 40 days, 82% after 120 days, and 77% after 180 days during the PREVENT-19 trial.
Opinion: The evidence is clear: A liquid-only diet before a colonoscopy is unnecessary
STAT
MARCH 19, 2024
Since colorectal cancer is on the rise in people younger than age 50, national guidelines have recently pushed the starting age for colorectal cancer screening down to 45. We need to spread the word. Yet we specialists continue to provide outdated and disproven recommendations on colonoscopy bowel preparation that make the process more difficult for the millions of patients who undergo colonoscopy every year: We tell them to adopt a clear liquid diet the day before their procedure.
Google's healthcare AI ambitions: New model for personal health coaching and next steps for gen AI
Fierce Healthcare
MARCH 19, 2024
Google is doubling down on its ambitions for healthcare AI by exploring how generative AI can help clinicians in medical decision-making, understand lab and imaging information and provide con | Google is hyper-focused on generative AI in healthcare, pushing forward research to advance gen AI capabilities that can help clinicians in medical decision-making, understand lab and imaging information and provide consumers with personalized health insights based on their wearable data.
FDA Issues Paper on the Responsible Use of Artificial Intelligence in Medical Research
Pharmacy Times
MARCH 19, 2024
The agency will focus on collaboration to protect public health; advancing regulatory approaches; developing standards, guidelines, and best practices; and supporting research that evaluates and monitors AI performance.
Veterans Reported Loss of Everyday Functioning After COVID-19 Pandemic
Drug Topics
MARCH 22, 2024
Researchers aimed to address the adverse effects of veterans with COVID-19 diagnoses 18 months after infections were documented.
STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’
STAT
MARCH 18, 2024
The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies. PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves.
WSJ: CMS broadens Part D coverage for obesity drugs
Fierce Healthcare
MARCH 21, 2024
Medicare Part D may cover obesity drugs when they secure approval for additional, medically accepted uses, according to a WSJ report.
FDA Advisory Committee Votes in Favor of Ide-Cel for Adult Patients With Multiple Myeloma
Pharmacy Times
MARCH 18, 2024
The decision to vote in favor of idecabtagene vicleucel comes after positive phase 3 trial results demonstrating its efficacy compared with standard regimens.
FDA Approves Rilpivirine For Treatment of HIV-1 in Pediatric Patients
Drug Topics
MARCH 21, 2024
Rilpivirine (Edurant Ped) effectively suppresses the HIV-1 virus in pediatric patients with HIV-1 RNA less than or equal to 100,000 copies/mL in combination with other antiretroviral therapies.
Top U.S. addiction researcher calls GLP-1 data for addiction ‘very, very exciting’
STAT
MARCH 21, 2024
Early data regarding the use of GLP-1 medications like Ozempic and Wegovy to treat addiction is “very, very, exciting,” Nora Volkow, the director of the National Institute on Drug Abuse, said Thursday. But even as she expressed enthusiasm for the new drugs’ potential, Volkow criticized pharmaceutical companies for neglecting a moral imperative to develop new addiction treatments — but acknowledged that the health system more broadly doesn’t incentivize drug com
Hippocratic AI banks $53M backed by General Catalyst, a16z, Memorial Hermann, UHS and other health systems
Fierce Healthcare
MARCH 19, 2024
Launched out of stealth about a year ago, Hippocratic AI launched its first generative AI product and pocketed $53 million in series A funding, the startup announced Monday. | Launched out of stealth about a year ago, Hippocratic AI launched its first generative AI product and pocketed $53 million in series A funding. The fresh funding boosts the company's valuation to $500 million.
Study Data Suggests Sustained Safety, Efficacy of Lanadelumab in Adolescents With HAE
Pharmacy Times
MARCH 21, 2024
The data comes from 2 phase 4 trials, ENABLE and EMPOWER, which evaluated lanadelumab and the outcomes of treatment in adolescents with hereditary angioedema.
Let's personalize your content